Increasing the efficacy of PD-1 inhibitors in HL using combination strategies

2 Views
administrator
administrator
08/04/23

David Bond, MD, The Ohio State University Comprehensive Cancer Center, Columbus, OH, summarizes various combination approaches being explored with PD-1 inhibitors for the treatment of Hodgkin lymphoma (HL), including combinations with LAG-3 inhibitors, chemotherapy, and antibody-drug conjugates (ADCs). This interview took place at the 17th International Conference on Malignant Lymphoma (ICML), held in Lugano, Switzerland.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Show more
0 Comments Sort By

    No comments found

    Facebook Comments

    Up next

    AL AMYLOIDOSIS: INITIAL MANAGEMENT STRATEGIES
    02:00:42
    AL AMYLOIDOSIS: INITIAL MANAGEMENT STRATEGIES
    administrator
    3 Views
    Management Strategies for GI Involvement with Amyloidosis
    00:18:40
    Management Strategies for GI Involvement with Amyloidosis
    administrator
    2 Views
    Bad News : Rapidly Increasing Colon/Rectum Cancer in India | Colostomy Bag Patients increases
    00:07:32
    Bad News : Rapidly Increasing Colon/Rectum Cancer in India | Colostomy Bag Patients increases
    administrator
    1 Views
    | VACCINE NATION | Efficacy of HPV Vaccine to combat the Cervical Cancer scourge
    00:36:59
    | VACCINE NATION | Efficacy of HPV Vaccine to combat the Cervical Cancer scourge
    administrator
    3 Views
    | VACCINE NATION | Efficacy of HPV Vaccine to combat the Cervical Cancer scourge
    00:36:59
    | VACCINE NATION | Efficacy of HPV Vaccine to combat the Cervical Cancer scourge
    administrator
    0 Views
    Future directions for checkpoint inhibitors in cutaneous lymphoma treatment
    00:01:35
    Future directions for checkpoint inhibitors in cutaneous lymphoma treatment
    administrator
    2 Views
    Dr. Lauren Pinter-Brown on Combination Therapies in CTCL
    00:01:05
    Dr. Lauren Pinter-Brown on Combination Therapies in CTCL
    administrator
    2 Views
    The benefits of combination approaches in CTCL
    00:01:08
    The benefits of combination approaches in CTCL
    administrator
    3 Views
    Dr. Ai on the Efficacy of Brentuximab Vedotin in Patients With Advanced Cutaneous T-Cell Lymphoma
    00:01:15
    Dr. Ai on the Efficacy of Brentuximab Vedotin in Patients With Advanced Cutaneous T-Cell Lymphoma
    administrator
    4 Views
    Immune checkpoint inhibitors for cutaneous T-cell lymphoma
    00:01:48
    Immune checkpoint inhibitors for cutaneous T-cell lymphoma
    administrator
    1 Views
    Combining targeted agents with checkpoint inhibitors in cutaneous T-cell lymphoma
    00:01:33
    Combining targeted agents with checkpoint inhibitors in cutaneous T-cell lymphoma
    administrator
    2 Views
    Emerging Strategies in the Treatment of Acute Lymphoblastic Leukemia
    00:13:22
    Emerging Strategies in the Treatment of Acute Lymphoblastic Leukemia
    administrator
    3 Views
    The side effects of BRAF/MEK inhibitors and how to manage them
    00:41:16
    The side effects of BRAF/MEK inhibitors and how to manage them
    administrator
    2 Views
    Dr. Johnson on Promise of Combination Therapy in Melanoma
    00:01:14
    Dr. Johnson on Promise of Combination Therapy in Melanoma
    administrator
    3 Views
    Ocular distribution and efficacy after suprachoroidal injection of AU-011 for ocular melanoma
    00:33:11
    Ocular distribution and efficacy after suprachoroidal injection of AU-011 for ocular melanoma
    administrator
    2 Views
    Reading Part C Worksheet: Pancreatic Cancer's Gradual Rise Increasing Relevance OET Online Clas
    00:15:00
    Reading Part C Worksheet: Pancreatic Cancer's Gradual Rise Increasing Relevance OET Online Clas
    administrator
    2 Views
    What Are the Long-Term Effects of JAK Inhibitors?
    00:02:29
    What Are the Long-Term Effects of JAK Inhibitors?
    administrator
    2 Views
    Moving Beyond JAK Inhibitors in Myeloproliferative Neoplasms
    00:02:01
    Moving Beyond JAK Inhibitors in Myeloproliferative Neoplasms
    administrator
    1 Views
    Are eosinophil-associated diseases increasing in prevalence? Or are there better diagnostic tools?
    00:02:02
    Are eosinophil-associated diseases increasing in prevalence? Or are there better diagnostic tools?
    administrator
    1 Views